0001562180-22-004813.txt : 20220603 0001562180-22-004813.hdr.sgml : 20220603 20220603174611 ACCESSION NUMBER: 0001562180-22-004813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nelli James Patrick Jr. CENTRAL INDEX KEY: 0001780883 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 22995984 MAIL ADDRESS: STREET 1: C/O HEALTH CATALYST, INC. STREET 2: 3165 E.MILLROCK DRIVE #400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-06-01 false 0001636422 Health Catalyst, Inc. HCAT 0001780883 Nelli James Patrick Jr. C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false President Common Stock 2022-06-01 4 F false 3241.00 14.2371 D 268502.00 D Common Stock 2022-06-01 4 F false 118.00 14.9522 D 268384.00 D Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). /s/ Daniel Orenstein, as Attorney-in-Fact 2022-06-03